Acute pancreatitis (AP) is an established complication in ALL treatment, associated with the use of asparaginase.[10] In Chen study, 4.00% (n = 353) of patients developed AAP (asparaginase-associated pancreatitis). The gene discussed is ASPG; the disease is alkaline phosphatase measurement.